Analysts' Actions: BCR BRCM COH PNRA WAT


American Campus Comm ( ACC) was downgraded at UBS to neutral from buy. Increasing expenses and dispositions to fund existing development pipeline can dilute earnings, UBS said. $37 price target.

AOL ( AOL) was initiated with a buy rating at Bank of America/Merrill Lynch. $47 price target. Company has an attractive 7% free cashflow yield, BofA/Merrill said.

AvalonBay ( AVB) was downgraded to hold at TheStreet Ratings.

BBCN Bancorp ( BBCN) was upgraded at BMO Capital to outperform. $17 price target. Valuation call, as the company can deliver above-average earnings growth, BMO Capital said.

CR Bard ( BCR) was upgraded at Goldman Sachs to neutral from sell. Negative catalysts have been realized, Goldman Sachs said. $132 price target.

CR Bard was upgraded at Piper Jaffray to overweight from neutral. $140 price target. Organic growth profile is improving, Piper Jaffray said.

Broadcom ( BRCM) was downgraded at Wedbush to neutral from outperform. $27 price target. Company will be hurt by a choppier mobile market, Wedbush said.

Coach ( COH) was downgraded at Bank of America/Merrill Lynch to neutral. Turnaround will take more time than expected, BofA/Merrill said. $54 price target.

Crocs ( CROX) was downgraded to hold at TheStreet Ratings.

DuPont ( DD) was upgraded at J.P. Morgan to overweight from neutral. $67 price target. Leveraged to an acceleration in global economic growth, J.P. Morgan said.

EOG Resources ( EOG) was downgraded at FBR Capital Markets to market perform from outperform. Valuation call, as the sector has made a big run year to date, FBR Capital Markets said.

Exelon ( EXC) was downgraded at Jefferies to underperform from hold. Valuation call, with $24.50 price target, Jefferies said.

Eaton Vance ( EV) was upgraded at Credit Suisse to outperform from underperform. $46 price target. Company is delivering solid organic growth in a difficult environment, Credit Suisse said.

Finish Line ( FINL) was upgraded at Canaccord Genuity to buy from hold. $28 price target. Running trends are improving, Canaccord Genuity said.

Fossil ( FOSL) was upgraded at Piper Jaffray to overweight from neutral. $147 price target. Estimates were also increased, as margins appear to be at an inflection point, Piper Jaffray said.

Medtronic ( MDT) was upgraded at Deutsche Bank to buy from hold. $66 price target. Company has several potential product catalysts, Deutsche Bank said.

Matador Resources ( MTDR) was downgraded at Canaccord Genuity to hold from buy. $21 price target. Company lacks near-term catalysts, Canaccord Genuity said.

If you liked this article you might like

EY's Greene Sees More Med Tech, CRO Deals Ahead

Deals of the Week: Waiting for Clarity

Merger Buzz Drives Akorn to Top of Health Chart in April

Deals of the Week: Reason for Optimism

Good Medicine Makes for 3 Good Charts